Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Silvia Tesei is active.

Publication


Featured researches published by Silvia Tesei.


European Journal of Human Genetics | 2002

Genetic analysis of Paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians

Massimiliano Bonafè; Francesca Marchegiani; Maurizio Cardelli; Fabiola Olivieri; Luca Cavallone; Simona Giovagnetti; Carlo Pieri; Maurizio Marra; Roberto Antonicelli; Leonarda Troiano; Paola Gueresi; Giovanni Passeri; Maurizio Berardelli; Giuseppe Paolisso; Michelangela Barbieri; Silvia Tesei; Rosemarie Lisa; Giovanna De Benedictis; Claudio Franceschi

Human Paraoxonase (PON1) is a High-Density Lipoprotein (HDL)-associated esterase that hydrolyses lipo-peroxides. PON1 has recently attracted attention as a protective factor against oxidative modification of LDL and may therefore play an important role in the prevention of the atherosclerotic process. Two polymorphisms have been extensively studied: a Leucine (L allele) to Methionine (M allele) substitution at codon 55, and a Glutamine (A allele) to Arginine (B allele) substitution at codon 192. We have examined these two aminoacidic changes in 579 people aged 20 to 65 years old, and 308 centenarians. We found that the percentage of carriers of the B allele at codon 192 (B+ individuals) is higher in centenarians than in controls (0.539 vs 0.447), moreover we found that among the B+ individuals, the phenomenon was due to an increase of people carrying M alleles at codon 55 locus. In conclusion, we propose that genetic variability at PON1 locus affects survival at extreme advanced age.


Cytometry Part A | 2006

Single and three-color flow cytometry assay for intracellular zinc ion availability in human lymphocytes with Zinpyr-1 and double immunofluorescence: Relationship with metallothioneins

Marco Malavolta; Laura Costarelli; Robertina Giacconi; Elisa Muti; Gianni Bernardini; Silvia Tesei; Catia Cipriano; Eugenio Mocchegiani

The amount of available intracellular zinc is pivotal to regulate many cellular processes, including oxidative stress response and apoptotic mechanisms. Therefore it is not surprising that zinc homeostasis and dyshomeostasis is involved in many physiological and pathological states, respectively. Cell permeable zinc probes allow intracellular applications with microscopy technology, but flow cytometry (FC) applications have been scarcely explored, albeit they can be suited to study zinc homeostasis in different cell types, including rare cells.


Annals of the New York Academy of Sciences | 2007

Zinc, metallothioneins, and longevity--effect of zinc supplementation: zincage study.

Eugenio Mocchegiani; Robertina Giacconi; Catia Cipriano; Laura Costarelli; Elisa Muti; Silvia Tesei; Cinzia Giuli; Roberta Papa; Fiorella Marcellini; Erminia Mariani; Lothar Rink; George Herbein; Audrey Varin; Tamas Fulop; Daniela Monti; Jolanta Jajte; George V. Dedoussis; Efstathios S. Gonos; Ioannis P. Trougakos; Marco Malavolta

Abstract:  Aging is an inevitable biological process that is associated with gradual and spontaneous biochemical and physiological changes and increased susceptibility to diseases. Because nutritional factors are involved in improving immune functions, metabolic harmony, and antioxidant defense, some nutritional factors, such as zinc, may modify susceptibility to disease and promote healthy aging. In vitro (human lymphocytes exposed to endotoxins) and in vivo (old or young mice fed with low zinc dietary intake) studies revealed that zinc is important for immune efficiency (innate and adaptive), antioxidant activity (supeoxide dismutase), and cell differentiation via clusterin/apolipoprotein J. Intracellular zinc homeostasis is regulated by metallothioneins (MT) via ion release through the reduction of thiol groups in the MT molecule. This process is crucial in aging because high MT levels are not able to release zinc, resulting in low intracellular free ion availability for biological functions. Improvement in these functions occurs in the elderly after physiological zinc supplementation. In this study, the selection of elderly subjects for zinc supplementation is discussed in relation to the genetic background of MT and pro‐inflammatory cytokines, such as interleukin‐6, because the latter is involved both in MT‐gene expression and in intracellular zinc homeostasis.


Mechanisms of Ageing and Development | 2003

In vitro IL-6 production by EBV-immortalized B lymphocytes from young and elderly people genotyped for -174 C/G polymorphism in IL-6 gene: a model to study the genetic basis of inflamm-aging.

Fabiola Olivieri; Massimiliano Bonafè; Simona Giovagnetti; Rosalia Stecconi; Maurizio Cardelli; Luca Cavallone; Liana Spazzafumo; Francesca Marchegiani; Giuseppina Carrieri; Elena Mugianesi; Claudia Giampieri; Matteo Centurelli; Raffaella Moresi; Silvia Tesei; Rosamaria Lisa; Claudio Viticchi; Lorenzo Falsetti; Stefano Salvioli; Claudio Franceschi

In the present investigation we analysed Interleukin 6 (IL-6) in vitro production by Epstein-Barr virus (EBV)-immortalized B lymphocytes established from 43 subjects, 15 young people and 28 elderly people, including 18 centenarians, after 3, 6, 9, 24, 48 and 72 h of culture. The subjects were genotypized for the C to G transition at nucleotide -174 of IL-6 gene promoter (-174 C/G) and were classified as C allele carriers (C+) and non-carriers (C-). We found that: (i) the interindividual difference in in vitro IL-6 production was wider in elderly individuals in respect to young individuals, leading to different coefficient of variation in the two groups; (ii) the -174 C/G polymorphism had an age-related effect on IL-6 in vitro production. Only among C- people, cells from elderly subjects produced significant higher level of IL-6 than cells from young subjects. These data are consistent with our previous results regarding the IL-6 serum levels in a large group of people of different age, including centenarians. Thus, the EBV-immortalized B lymphocytes can be considered a useful in vitro model for studying the genetic control of IL-6 production and its changes with age.


Journals of Gerontology Series A-biological Sciences and Medical Sciences | 2009

Accumulation of Cells With Short Telomeres Is Associated With Impaired Zinc Homeostasis and Inflammation in Old Hypertensive Participants

Catia Cipriano; Silvia Tesei; Marco Malavolta; Robertina Giacconi; Elisa Muti; Laura Costarelli; Francesco Piacenza; Sara Pierpaoli; Roberta Galeazzi; Maria A. Blasco; Elsa Vera; Andrés Canela; Fabrizia Lattanzio; Eugenio Mocchegiani

Critical shortening of telomeres, likely associated with a considerable increase of senescent cells, can be observed in PBMC of individuals aged 80 and older. We investigated the relationship between critical telomere shortening and zinc status in healthy or hypertensive participants with or without cardiovascular disease in old and very old participants. Telomere shortening and accumulation of cells with short telomeres (percent of cells with short telomeres) in advancing age was evident in patients and healthy controls, but exacerbated in those patients aged 80 and older. Moreover, in very old patients, the accumulation of % CST may impair intracellular zinc homeostasis and metallothioneins expression, which itself is linked to an increased number of inflammatory agents, thereby suggesting the existence of a possible causal relationship between % CST and zinc homeostasis. The determination of % CST could be a more reliable means than the simple measure of telomere length as fundamental parameter in ageing to determine whether individuals are still able to respond to stress.


Rejuvenation Research | 2008

Metallothionein downregulation in very old age: a phenomenon associated with cellular senescence?

Marco Malavolta; Catia Cipriano; Laura Costarelli; Robertina Giacconi; Silvia Tesei; Elisa Muti; Francesco Piacenza; Sara Pierpaoli; Annis Larbi; Graham Pawelec; George Dedoussis; George Herbein; Daniela Monti; Jolanta Jajte; Lothar Rink; Eugenio Mocchegiani

It is known that metallothionein (MT) mRNA expression first increases with age, but then decreases again in the very elderly. Here we report that MT protein levels also decrease in very old age, and that this is independent of dietary zinc intake. Age-related changes of MT, as well as alterations of zinc homeostasis (intracellular labile zinc and NO-induced zinc release), occur both in human PBMCs ex vivo and also in CD4+ T cell clones progressing through their finite life span in vitro. These results suggest that phenomena observed in very old people can be at least partially attributed to diminished cell proliferation.


Journal of Nutritional Biochemistry | 2010

Association of MT1A haplotype with cardiovascular disease and antioxidant enzyme defense in elderly Greek population: comparison with an Italian cohort.

Robertina Giacconi; Stavroula Kanoni; Patrizia Mecocci; Marco Malavolta; Dimitris Richter; Sara Pierpaoli; Laura Costarelli; Catia Cipriano; Elisa Muti; Francesca Mangialasche; Francesco Piacenza; Silvia Tesei; Roberta Galeazzi; Eirini V. Theodoraki; Fabrizia Lattanzio; George Dedoussis; Eugenio Mocchegiani

Metallothioneins (MT), the antioxidant zinc-binding proteins, seem to mediate cardioprotection. It has been postulated that zinc homeostasis and MT function may be altered, as a consequence of oxidative stress, in cardiovascular disease (CVD), with a potential implication of MT genetic polymorphisms. The present study explores the role of +647A/C and +1245A/G MT1A polymorphisms on the susceptibility to CVD, zinc status and enzyme antioxidant activity, in the Greek and Italian populations. The country selection was based on the lower zinc status and the reduced zinc dietary intake in Greece than in Italy despite the similar Mediterranean dietary pattern. A total of 464 old, healthy control subjects and 369 old CVD patients more than 70 years of age were studied. Logistic regression model indicated that +1245 MT1A G+ genotype significantly increased the risk of CVD in Greece (34.4% vs. 23.2%; odds ratio=1.88, 95% confidence interval=1.14-3.08; P=.013) but not in Italy. Haplotype analysis showed an increment of CG haplotype frequency in CVD Greek patients (17.4% vs. 10.6%, P<.05). Differential country-related frequency distribution was also recorded. Applying a multivariate regression model, +647/+1245 MT1A haplotype was associated with a modulation of enzyme antioxidant activities in both countries. Decreased plasma zinc and reduced intracellular Zn release, as well as increased enzyme antioxidant activity, were more apparent in Greek healthy donors than in Italy. In conclusion, +1245 MT1A polymorphism and +647/+1245 MT1A haplotype are implicated in CVD in Greece but not in Italy, suggesting a role of gene-diet interaction in the disease predisposition.


Oncology Research | 2009

In vivo effect of alpha-bisabolol, a nontoxic sesquiterpene alcohol, on the induction of spontaneous mammary tumors in HER-2/neu transgenic mice.

Laura Costarelli; Marco Malavolta; Robertina Giacconi; Catia Cipriano; Nazzarena Gasparini; Silvia Tesei; Sara Pierpaoli; Fiorenza Orlando; Hisanori Suzuki; Luigi Perbellini; Francesco Piacenza; Monica Emanuelli; Eugenio Mocchegiani

Breast cancer represents the most commonly diagnosed invasive malignancy in pre- and postmenopausal women in both developed and underdeveloped countries. Taking into account that treatment options, including surgery, have not been able to deal with the growing incidence of breast malignancy, it is required to develop mechanism-based novel agents for its prevention. Wide interest in some natural compounds as antiinflammatory agents and as alternative to the traditional medicines is increasing because they do not provoke any adverse effects and are effective in multiple organs, alpha-Bisabolol (BISA), a small oily sesquiterpene alcohol, was reported as chemopreventive agent in induced rat mammary carcinogenesis. The aim of the present study is to investigate the role played by two doses of BISA (via intramammary infusion) on the induction and development of mammary tumor in HER-2/neu transgenic mice as well as the BISA effect after tumor surgical resection. The main data show that (a) optimal dosage of BISA is 10 mg/mouse rather than 3.6 mg/mouse with no adverse effects (e.g., alopecia); (b) the number of the palpable tumor masses decreases in mice treated with 10 mg/mouse of BISA; (c) mice after surgical resection of the primary tumor and treatment with BISA (10 mg) are free from tumor for more weeks, after the surgical treatment; (d) using array analysis, some genes implicated in carcinogenesis mechanisms (NF-kappaBia, Map2k, Mapkl4, and HER2/ neu), angiogenesis process (Fgf), and inhibition of apoptosis (Birc5) are differently regulated after BISA treatment, with a downregulation of the HER2/neu as well as of Fgf and Birc5 genes; (e) the NK cell cytotoxicity increases in tumor-treated mice, especially after the removal of the first tumor mass. Such effectiveness could be important to achieve goals for a possible combination of BISA to conventional therapies in breast cancer and to tumor surgical removal (adjuvant therapy), as suggested for other sesquiterpene analogs.


Rejuvenation Research | 2008

A Novel Zip2 Gln/Arg/Leu Codon 2 Polymorphism Is Associated with Carotid Artery Disease in Aging

Robertina Giacconi; Elisa Muti; Marco Malavolta; Maurizio Cardelli; Sara Pierpaoli; Catia Cipriano; Laura Costarelli; Silvia Tesei; Vittorio Saba; Eugenio Mocchegiani

Zinc deficiency represents a risk factor for carotid stenosis (CS) development. In mammals, members of the ZIP family regulate zinc uptake, and hZip2 is a human zinc importer upregulated by zinc depletion. The purpose of this study was to investigate the association of a novel Zip2 Gln/Arg/Leu codon 2 polymorphism with CS, analyzing 250 CS patients and 259 elderly controls. CS patients showed an increased GG genotype frequency (60% vs. 47.5%), and a reduced TT frequency (6% vs. 10%) (p < 0.05 by chi(2) test). In conclusion, Zip2 Gln/Arg/Leu polymorphism plays a role in the susceptibility to carotid artery disease.


Journal of Analytical Atomic Spectrometry | 2007

Combining UHR-SEC-HPLC-ICP-MS with flow cytometry to quantify metallothioneins and to study zinc homeostasis in human PBMC

Marco Malavolta; Francesco Piacenza; Laura Costarelli; Robertina Giacconi; Elisa Muti; Catia Cipriano; Silvia Tesei; Sandro Spezia; Eugenio Mocchegiani

A simple ultra high resolution (UHR)-size exclusion HPLC (SEC-HPLC) system with online detection by ICP-MS was set-up to quantify metallothioneins (MT), Zn bound to MT and to other cytosolic protein fractions with defined molecular weight in human peripheral blood mononuclear cells (PBMC). Applications of this method in combination with flow cytometry (FC) offer powerful diagnostic approaches for the evaluation of the zinc status and for quantifying MT in a very small sample amount.

Collaboration


Dive into the Silvia Tesei's collaboration.

Top Co-Authors

Avatar

Laura Costarelli

Nuclear Regulatory Commission

View shared research outputs
Top Co-Authors

Avatar

Marco Malavolta

Nuclear Regulatory Commission

View shared research outputs
Top Co-Authors

Avatar

Catia Cipriano

Nuclear Regulatory Commission

View shared research outputs
Top Co-Authors

Avatar

Elisa Muti

Nuclear Regulatory Commission

View shared research outputs
Top Co-Authors

Avatar

Eugenio Mocchegiani

Nuclear Regulatory Commission

View shared research outputs
Top Co-Authors

Avatar

Francesco Piacenza

Marche Polytechnic University

View shared research outputs
Top Co-Authors

Avatar

Fabrizia Lattanzio

Nuclear Regulatory Commission

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cinzia Giuli

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Fiorella Marcellini

Nuclear Regulatory Commission

View shared research outputs
Researchain Logo
Decentralizing Knowledge